miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.
about
Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detectionMicroRNAs show mutually exclusive expression patterns in the brain of adult male ratsEstrogen receptor {beta}1 expression is regulated by miR-92 in breast cancermiR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNAMicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma developmentA pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasisMiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast CancerRoles of the canonical myomiRs miR-1, -133 and -206 in cell development and diseaseMicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast CancerThe Akt-associated microRNAsMicroRNAs in autophagy and their emerging roles in crosstalk with apoptosisMicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancerGenetic variation in a hsa-let-7 binding site in RAD52 is associated with breast cancer susceptibilityLet-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancerProtein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell linesThe Ddx5 and Ddx17 RNA helicases are cornerstones in the complex regulatory array of steroid hormone-signaling pathwaysNuclear receptor SHP activates miR-206 expression via a cascade dual inhibitory mechanism.MicroRNA-206 targets notch3, activates apoptosis, and inhibits tumor cell migration and focus formation.Serum MicroRNAs Related with Chemoradiotherapy Resistance in Advanced-Stage Cervical Squamous Cell Carcinoma.MicroRNA-206 suppresses gastric cancer cell growth and metastasis.microRNA, cell cycle, and human breast cancer.MicroRNA-101-mediated Akt activation and estrogen-independent growth.Proteasome inhibition represses ERalpha gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancerMicroRNA regulation in Ames dwarf mouse liver may contribute to delayed aging.MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer.Epigenetics meets endocrinology.Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patients.MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas.MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines.microRNA and cancerThe expression and significance of five types of miRNAs in breast cancerRegulation of nucleolin expression by miR-194, miR-206, and HuR.ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approachesIdentification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous cell carcinomaTherapeutic implications of microRNAs in pulmonary arterial hypertension.Identification and pathway analysis of microRNAs with no previous involvement in breast cancer.microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers.MicroRNA-27a promotes proliferation and suppresses apoptosis by targeting PLK2 in laryngeal carcinomaNoncanonical mechanisms to regulate nuclear receptor signaling.Small players with big roles: microRNAs as targets to inhibit breast cancer progression.
P2860
Q21134914-2E1CE49A-27BC-4568-83EB-8D9EB701B8AEQ21142742-9686822D-91D0-4CA0-8A5D-B0F7ADB0ADADQ24595552-3F15D66D-2912-403F-B122-74295CA57368Q24644154-582C7A49-4867-48EC-A042-E3E0A586253FQ24648202-82624DA3-DAE5-4128-907C-E18EB576903DQ24649156-61A10EAD-D865-4F9E-AE20-56FB9622270AQ26775086-50CC614E-2E22-404D-9003-5657C66159E5Q26795757-155253D9-D15B-41FE-B310-1234C6E7EDABQ26801108-A431FDEF-466D-415B-B213-EBBBC2ECA5DDQ26830734-8334BD3F-8F10-4131-897C-A14CBA67AD35Q27008099-B0C3A26D-C236-4E67-AEE4-830451BB9A01Q28114800-0E58766C-8E88-489F-8ED0-A62C488D925EQ28280159-1BBDFB4E-4E0C-400B-A22B-384D17473171Q28284772-CF44BED7-2FB9-4456-B74D-1BD0E48A48A1Q28651483-6F7F6A60-A3B1-4325-8120-AD4719A012C4Q28854594-0AE2201A-EBB6-49E4-B651-AAB2B092D240Q33498938-48747EE9-3A49-4F93-AA3F-2FE8B58CC244Q33553774-364A9EDA-6B54-40AC-B60C-9DB0CCD0F3A3Q33581586-52B86D7C-8F95-41B8-8433-A5B91011F090Q33648209-74C9A70E-D51F-43C6-93E1-AF2AA5F3E468Q33703585-B9A3E326-B2E2-4876-BAEB-E33BA02D9CB6Q33721789-BECAE390-F172-447F-AC48-C2BC29A5A386Q33721926-52B2B40C-0FA6-4D1A-B1AC-5B901432A7E7Q33750015-C9EA80B9-F16B-4493-8BF4-998F2EAAC34EQ33785102-2683A829-FE00-4266-BF1B-63BCAB954D94Q33810295-122C6A95-1749-4F5F-AD96-6B3B9D5D6519Q33894799-78BBB4C5-A420-4442-8FAD-A057AEAFB8E6Q33906031-6AEC5B78-60C7-4AC4-9E42-24B58CA5A357Q33932172-0963B294-D860-488F-80EF-6B3BAD61AAB8Q33954625-8731589C-D629-4BB4-9D1A-FAD1B535A03CQ33983042-E40C64D2-63FC-4977-864D-5693E88EBBD8Q34046874-643B66D7-5630-42CB-BE75-AFDA97A2F5ADQ34119028-D78F4772-5561-4BB6-9B47-D21007962669Q34150057-5142B238-9D2C-4675-8780-282B5D636E37Q34179986-45BBF996-B14E-4CC4-9584-02CE30472F22Q34206037-21D02E7D-A7CA-4302-BD6D-E32B720AC352Q34252329-62289B74-5463-4352-AC8B-7F2BC761403EQ34253848-ADAB18B2-D7F4-4E53-9A94-C335DD88C54EQ34338685-7DAE14D8-497D-473E-A7FB-537AC5A2D5D2Q34425882-0C69101A-A80D-4152-904F-9EE3963399FC
P2860
miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
miR-206 Expression is down-reg ...... -positive human breast cancer.
@ast
miR-206 Expression is down-reg ...... -positive human breast cancer.
@en
miR-206 Expression is down-reg ...... -positive human breast cancer.
@nl
type
label
miR-206 Expression is down-reg ...... -positive human breast cancer.
@ast
miR-206 Expression is down-reg ...... -positive human breast cancer.
@en
miR-206 Expression is down-reg ...... -positive human breast cancer.
@nl
prefLabel
miR-206 Expression is down-reg ...... -positive human breast cancer.
@ast
miR-206 Expression is down-reg ...... -positive human breast cancer.
@en
miR-206 Expression is down-reg ...... -positive human breast cancer.
@nl
P2093
P1433
P1476
miR-206 Expression is down-reg ...... -positive human breast cancer.
@en
P2093
Hiroko Yamashita
Hiroshi Sugiura
Naoto Kondo
Tatsuya Toyama
Yoshitaka Fujii
P304
P356
10.1158/0008-5472.CAN-08-0180
P407
P577
2008-07-01T00:00:00Z